Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management
Truong, Hong, Ravichandran, Vignesh, Kemel, Yelena, Knezevic, Andrea, Gleeson, Jack Patrick, Benfante, Nicole, Bromberg, Maria, Bolos, Mary, Joseph, Gabriella, Matulewicz, Richard, Sheinfeld, Joel, Funt, Samuel Aaron, McHugh, Deaglan Joseph, Bajorin, Dean F., Donoghue, Mark, Stadler, Zsofia Kinga, Feldman, Darren R.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT)
Funt, Samuel A, Knezevic, Andrea, Freeman, Benjamin A, Bolos, Mary, Martorana, Victoria, Donoghue, Mark, Khan, Shah, Singh, Harleen, Bromberg, Maria, Quinlan, Colleen, Carousso, Maryann, Jungbluth, Achim A., Patil, Sujata, Shah, Neil J., Lee, Chung-Han, McHugh, Deaglan Joseph, Al-Ahmadie, Hikmat A., Feldman, Darren R.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article